参考文献/References:
[1] NEW P W,CRIPPS R A,BONNE LEE B.Global maps of non-traumatic spinal cord injury epidemiology:towards a living data repository[J].Spinal Cord,2014,52(2):97-109.
[2] WU J C,KO C C,YEN Y S,et al.Epidemiology of cervical spondylotic myelopathy and its risk of causing spinal cord injury:a national cohort study[J].Neurosurg Focus,2013,35(1):E10.
[3] KADANKA Z,BEDNAÍK J,NOVOTN O,et al.Cervical spondylotic myelopathy:conservative versus surgical treatment after 10 years[J].Eur Spine J,2011,20(9):1533-1538.
[4] 朱立国,唐彬,银河,等.益肾养髓方治疗脊髓型颈椎病35例[J].中国中医骨伤科杂志,2018,26(6):56-58.
[5] 银河,陈琳,陈忻,等.脊髓型颈椎病动物模型的研究现状[J].中华中医药杂志,2021,36(1):354-357.
[6] KOVALOVA I,KERKOVSKY M,KADANKA Z,et al.Prevalence and imaging characteristics of nonmyelopathic and myelopathic spondylotic cervical cord compression[J].Spine(Phila Pa 1976),2016,41(24):1908-1916.
[7] KARADIMAS S K,ERWIN W M,ELY C G,et al.Pathophysiology and natural history of cervical spondylotic myelopathy[J].Spine(Phila Pa 1976),2013,38(22 Suppl 1):S21-S36.
[8] BADHIWALA J H,AHUJA C S,AKBAR M A,et al.Degenerative cervical myelopathy-update and future directions[J].Nat Rev Neurol,2020,16(2):108-124.
[9] KUROKAWA R,MURATA H,OGINO M,et al.Altered blood flow distribution in the rat spinal cord under chronic compression[J].Spine(Phila Pa 1976),2011,36(13):1006-1009.
[10] YU W R,BAPTISTE D C,LIU T,et al.Molecular mechanisms of spinal cord dysfunction and cell death in the spinal hyperostotic mouse:implications for the pathophysiology of human cervical spondylotic myelopathy[J].Neurobiol Dis,2009,33(2):149-163.
[11] YU W R,LIU T,KIEHL T R,et al.Human neuropathological and animal model evidence supporting a role for Fas-mediated apoptosis and inflammation in cervical spondylotic myelopathy[J].Brain,2011,134(Pt 5):1277-1292.
[12] 唐彬,朱立国,陈忻,等.益肾养髓方对脊髓型颈椎病大鼠受损脊髓微血管再生的影响[J].中国中医药信息杂志,2022,29(5):51-55.
[13] 杨博文,朱立国,陈忻,等.益肾养髓方对脊髓型颈椎病大鼠小胶质细胞极化的影响[J].中国中医骨伤科杂志,2023,31(3):1-5.
[14] 秦晓宽,银河,杨博文,等.益肾养髓方对脊髓型颈椎病大鼠脊髓中星形胶质细胞过度增殖的影响[J].中药新药与临床药理,2022,33(2):173-179.
[15] 唐彬,银河,杨博文,等.益肾养髓方对脊髓型颈椎病大鼠脊髓中神经营养因子表达的影响及其神经修复作用研究[J].中国全科医学,2021,24(3S):4447-4456.
[16] DOLAN R T,BUTLER J S,O'BYRNE J M,et al.Mechanical and cellular processes driving cervical myelopathy[J].World Journal of Orthopedics,2016,7(1):20-29.
[17] LETELLIER E,KUMAR S,SANCHO-MARTINEZ I,et al.CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site[J].Immunity,2010,32(2):240-252.
[18] MOON E S,KARADIMAS S K,YU W R,et al.Riluzole attenuates neuropathic pain and enhances functional recovery in a rodent model of cervical spondylotic myelopathy[J].Neurobiol Dis,2014,62:394-406.
[19] FEHLINGS M G,BADHIWALA J H,AHN H,et al.Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy(CSM-Protect):a multicentre,double-blind,placebo-controlled,randomised,phase 3 trial[J].Lancet Neurol,2021,20(2):98-106.